Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
Lenz Therapeutics (LENZ)  
$16.52 0.35 (2.07%) as of 4:30 Mon 12/29


Download
   
  Company Roster

Total Insiders  : 18  
Total Direct Shares :
21,460,550
Total Indirect Shares :
18,452,241
 
% Held by Insiders:
68.59%
 
9 other people own 
 $16,707,568 Versant Ventures Vii Gp-G...
 $17,355,895 Lehrer-Graiwer Joshua
 $19,190,788 Porteus Matthew
 $58,291,299 Versant Vantage Ii Gp-Gp,...
 $242,982,735  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Olsson Shawn Chief Commercial Officer 2025-11-17 4,733 2024-12-16 0
   Chevallard Daniel R. Chief Financial Officer 2025-11-07 5,386 2024-05-14 0
   Mccollum James W Director 2025-11-07 10,500 2025-11-07 620,599
   Versant Ventures Vii Gp-Gp, Llc 2025-09-30 1,050,599 2025-09-30 1,606,289
   Schimmelpennink Evert B. President, CEO and Secretary, Director 2025-03-07 49,200 2024-07-22 0
   Odrich Marc Chief Medical Officer 2024-03-21 99,599 2024-03-21 0
   Shah Rajeev M. Director, 10% Owner 2024-03-21 0 2024-03-21 694,755
   Gutry Phil CHIEF BUSINESS OFFICER 2022-04-11 299,941 0
   Akkaraju Srinivas 10% Owner 2021-06-29 0 2022-04-12 8,497,067
   Versant Vantage Ii Gp-Gp, Llc 10% Owner 2021-06-29 14,708,398 2021-06-29 1,707,719
   Lehrer-Graiwer Joshua PRESIDENT AND CEO, Director 2021-06-29 1,161,670 0
   Stultz Katherine V CHIEF OPERATING OFFICER 2021-06-29 216,020 0
   Karsen Perry A Director 2021-06-29 164,034 0
   Shah Smital Director 2021-06-29 0 2021-06-29 5,882
   Jimenez Joseph Director 2021-06-29 161,941 0
   Porteus Matthew Director 2021-06-24 3,528,529 0
   Jerel Davis Director, 10% Owner 0 2021-06-29 1,707,719
   Chimera Investment Llc 10% Owner 0 2024-03-21 3,612,211
18 Records found